Unipolare Depression Langfassung - Versorgungsleitlinien.de

243. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
244. Bech P, Rafaelsen OJ. The melancholia scale development, consistency, validity and utility.
In: Satorius N, Ban TA, editors. Assessment of depression. Berlin: Springer; 1986.
245. Stieglitz RD, Wolfersdorf M, Metzger R, Ruppe A, Stabenow S, Hornstein C, Keller F, Schell
G, Berger M. Stationäre Behandlung depressiver Patienten. Konzeptuelle Überlegungen und
Ergebnisse eines Pilotprojekts zur Qualitätssicherung in Baden-Württemberg. Nervenarzt
1998;69(1):59-65.
246. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J
Psychiatry 1979;134:382-9.
247. Neumann N, Schulte R. Montgomery-Asperg-Depressions-Rating-Skala zur
psychometrischen Beurteilung depressiver Syndrome. Deutsche Fassung. Erlangen: Perimed-
Fachbuch; 1989.
248. Ferrier IN. Treatment of major depression: is improvement enough? J Clin Psychiatry 1999;60
Suppl 6:10-4.
249. Keller MB. Past, present, and future directions for defining optimal treatment outcome in
depression: remission and beyond. JAMA 2003;289(23):3152-60.
250. Lecrubier Y. How do you define remission? Acta Psychiatr Scand Suppl 2002;(415):7-11.
251. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of
depression. J Clin Psychiatry 1999;60 Suppl 22:7-11.
252. Paykel ES. Achieving gains beyond response. Acta Psychiatr Scand Suppl 2002;(415):12-7.
253. Rudolph RL. Goal of antidepressant therapy: response or remission and recovery? J Clin
Psychiatry 1999;60 Suppl 6:3-4.
254. Thase ME. Redefining antidepressant efficacy toward long-term recovery. J Clin Psychiatry
1999;60 Suppl 6:15-9.
255. Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry
2003;64 Suppl 2:3-7.
256. Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin
Psychiatry 2003;64 Suppl 13:18-25.
257. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Attiullah N, Boerescu D. How
should remission from depression be defined? The depressed patient's perspective. Am J
Psychiatry 2006;163(1):148-50.
258. Department of Veterans Affairs (VA). VHA/DOD Clinical Practice Guideline for the
Management of Major Depressive Disorder in Adults. Version 2.0. 2000 [cited: 2005 Jul 07].
Available from: http://www.oqp.med.va.gov/cpg/MDD/MDD_GOL.htm
259. Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, de Battista C, Nelson
JC, Nierenberg AA, Sackeim HA, Thase ME. The Texas Medication Algorithm Project: report
of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive
Disorder. J Clin Psychiatry 1999;60(3):142-56.
260. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major
depression. Harv Rev Psychiatry 1998;5(6):293-306.
261. Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression:
the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry 2003;64 Suppl
15:13-7.
262. Petersen TJ. Enhancing the efficacy of antidepressants with psychotherapy. J
Psychopharmacol 2006;20(3 Suppl):19-28.
263. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran
AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent
depression. Arch Gen Psychiatry 1990;47(12):1093-9.
264. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive
behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004;161(10):1872-
6.
© 2009 213